The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease
出版年份 2016 全文链接
标题
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease
作者
关键词
-
出版物
LIVER INTERNATIONAL
Volume 36, Issue 10, Pages 1549-1557
出版商
Wiley
发表日期
2016-04-23
DOI
10.1111/liv.13150
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)
- (2016) Henning Grønbæk et al. JOURNAL OF HEPATOLOGY
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery
- (2015) Konstantin Kazankov et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
- (2015) Jessica L Mueller et al. Clinical and Translational Gastroenterology
- Hepatic Macrophage Activation and the LPS Pathway in Patients With Alcoholic Hepatitis: A Prospective Cohort Study
- (2014) Thomas Damgaard Sandahl et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C
- (2014) Konstantin Kazankov et al. HEPATOLOGY
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
- (2014) Pierre Bedossa et al. HEPATOLOGY
- Macrophage heterogeneity in liver injury and fibrosis
- (2014) Frank Tacke et al. JOURNAL OF HEPATOLOGY
- Intrahepatic fat content correlates with soluble CD163 in relation to weight loss induced by Roux-en-Y gastric bypass
- (2014) Karen Fjeldborg et al. Obesity
- Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease - the role of transient elastography and plasma cytokeratin-18 fragments
- (2013) R. Kwok et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Hepatic macrophage activation predicts clinical decompensation in chronic liver disease
- (2013) Anthony Rode et al. GUT
- Structural Basis for Inflammation-driven Shedding of CD163 Ectodomain and Tumor Necrosis Factor-α in Macrophages
- (2013) Anders Etzerodt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis
- (2013) Oliver Waidmann et al. JOURNAL OF HEPATOLOGY
- The Macrophage-Specific Serum Marker, Soluble CD163, Is Increased in Obesity and Reduced After Dietary-Induced Weight Loss
- (2013) Karen Fjeldborg et al. Obesity
- Hepatic Crown-Like Structure: A Unique Histological Feature in Non-Alcoholic Steatohepatitis in Mice and Humans
- (2013) Michiko Itoh et al. PLoS One
- Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis
- (2012) H. Grønbaek et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Soluble CD163: a biomarker linking macrophages and insulin resistance
- (2012) T. Parkner et al. DIABETOLOGIA
- Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production
- (2012) Annie-Carole Tosello-Trampont et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States
- (2012) Zobair M. Younossi et al. MEDICINE
- Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS
- (2011) P. Holland-Fischer et al. GUT
- Soluble CD163
- (2011) Holger J. Møller SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Serum Soluble CD163 Predicts Risk of Type 2 Diabetes in the General Population
- (2010) H. J. Moller et al. CLINICAL CHEMISTRY
- Increased tumor necrosis factor α-converting enzyme activity induces insulin resistance and hepatosteatosis in mice
- (2009) Loredana Fiorentino et al. HEPATOLOGY
- Kupffer cells promote hepatic steatosis via interleukin-1β-dependent suppression of peroxisome proliferator-activated receptor α activity
- (2009) Rinke Stienstra et al. HEPATOLOGY
- Kupffer cells in non-alcoholic fatty liver disease: The emerging view
- (2009) György Baffy JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More